{"id":229074,"date":"2026-09-03T11:21:16","date_gmt":"2026-09-03T05:51:16","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=229074"},"modified":"2026-09-03T11:21:16","modified_gmt":"2026-09-03T05:51:16","slug":"why-ipca-laboratories-share-price-fall-today-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-ipca-laboratories-share-price-fall-today-2026\/","title":{"rendered":"Ipca Laboratories (IPCALAB) Share Price Falls 2.32% to Rs 1,911"},"content":{"rendered":"
Ipca Laboratories (IPCALAB)<\/a>share price fell to Rs 1,911 today, down 2.32% from the previous close. Market cap was Rs 50,384.39 crore.<\/em><\/div>\n

Ipca Laboratories Share Price fell to Rs 1,911 on 03 September 2026 at 11:19:38 AM IST, down 2.32% for the day, taking the company\u2019s market capitalisation to Rs 50,384.39 crore. The stock declined by Rs 45.35 from its previous close of Rs 1,956.35, making it one of the healthcare names drawing attention in today\u2019s market update.<\/p>\n

For investors trackingIpca Laboratories Share Price<\/strong>today, the verified data confirms a meaningful single-session decline, but it does not establish a company-specific catalyst behind the move. The stock is trending because the price action was notable within a Large Cap pharmaceutical name, while its valuation and profitability metrics remain important: P\/E stands at 37.89, P\/B at 5.85, ROE at 15.88 and ROCE at 19.41. Investors may also watch how the stock behaves around its intraday low of Rs 1,907.6, how it compares with sector benchmarks, and whether its premium multiples remain supported by returns on capital. Univest data also shows the stock still trading above its 50-day and 200-day moving averages, which adds useful context even on a down day.<\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n